The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach

Icosapent Ethyl for Treatment of Elevated Triglyceride Levels

(2014) Scott D. Nelson et al.   ANNALS OF PHARMACOTHERAPY

Brugada Syndrome ECG Is Highly Prevalent in Schizophrenia

(2014) Marieke T. Blom et al.   Circulation-Arrhythmia and Electrophysiology

Sex-Related Differences in the Effect-Site Concentration of Remifentanil for Preventing QTc Interval Prolongation Following Intubation in Elderly Patients with a Normal QTc Interval

(2014) S. Y. Kim et al.   DRUGS & AGING

Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management

(2014) S. Fanoe et al.   EUROPEAN HEART JOURNAL

Management of Psychosis and Agitation in Medical-Surgical Patients Who Have or Are at Risk for Prolonged QT Interval

(2014) ROSE RIES et al.   Journal of Psychiatric Practice

Comparative mortality risks of antipsychotic medications in community-dwelling older adults

(2013) T. Gerhard et al.   BRITISH JOURNAL OF PSYCHIATRY

Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United States

(2013) M. Levine et al.   CLINICAL TOXICOLOGY

Termination of Clozapine Treatment Due to Medical Reasons

(2013) Jimmi Nielsen et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe

(2013) Emanuel Raschi et al.   PLoS One

QTc prolongation and clozapine: Fact or artefact?

(2012) Jimmi Nielsen   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics

(2011) Jimmi Nielsen et al.   CNS DRUGS

The safety of atypical antipsychotics: does QTc provide all the answers?

(2011) Jimmi Nielsen   Expert Opinion On Drug Safety

The effect of sertindole on QTD and TPTE

(2010) J. Nielsen et al.   ACTA PSYCHIATRICA SCANDINAVICA

Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?

(2010) Christoph U. Correll et al.   ACTA PSYCHIATRICA SCANDINAVICA

Identification of Human Ether-à-go-go Related Gene Modulators by Three Screening Platforms in an Academic Drug-Discovery Setting

(2010) Xi-Ping Huang et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales

(2010) Kirsten Windfuhr et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Identifying Drug-Induced Repolarization Abnormalities from Distinct ECG Patterns in Congenital Long QT Syndrome

(2009) Claus Graff et al.   DRUG SAFETY

Sertindole causes distinct electrocardiographic T-wave morphology changes

(2009) Jimmi Nielsen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Quantitative Analysis of T-wave Morphology Increases Confidence in Drug-Induced Cardiac Repolarization Abnormalities: Evidence From the Investigational IKrInhibitor Lu 35-138

(2009) Claus Graff et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sudden cardiac death secondary to antidepressant and antipsychotic drugs

(2008) Serge Sicouri et al.   Expert Opinion On Drug Safety

TpeakTend interval in long QT syndrome

(2008) Jorgen K. Kanters et al.   JOURNAL OF ELECTROCARDIOLOGY

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH